Veritas Investment Management’s AbbVie ABBV Stock Holding History

Veritas Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,400	Closed	-$123K	–	2
2020 Q3	$123K	Hold	1,400	–	–	0.01%	50
2020 Q2	$137K	Hold	1,400	–	–	0.01%	52
2020 Q1	$106K	Hold	1,400	–	–	0.01%	57
2019 Q4	$124K	Hold	1,400	–	–	0.01%	48
2019 Q3	$106K	Hold	1,400	–	–	0.01%	59
2019 Q2	$102K	Hold	1,400	–	–	0.01%	52
2019 Q1	$113K	Hold	1,400	–	–	0.01%	52
2018 Q4	$129K	Hold	1,400	–	–	0.02%	49
2018 Q3	$132K	Hold	1,400	–	–	0.01%	55
2018 Q2	$130K	Sell	1,400 -200	-13%	-$19.5K	0.02%	44
2018 Q1	$151K	Hold	1,600	–	–	0.02%	41
2017 Q4	$155K	Hold	1,600	–	–	0.02%	43
2017 Q3	$142K	Hold	1,600	–	–	0.02%	44
2017 Q2	$116K	Hold	1,600	–	–	0.02%	46
2017 Q1	$104K	Hold	1,600	–	–	0.02%	53
2016 Q4	$100K	Hold	1,600	–	–	0.02%	56
2016 Q3	$101K	Sell	1,600 -150	-9%	-$9.71K	0.02%	58
2016 Q2	$108K	Sell	1,750 -50	-3%	-$3.05K	0.02%	59
2016 Q1	$103K	Sell	1,800 -150	-8%	-$8.36K	0.02%	60
2015 Q4	$115K	Hold	1,950	–	–	0.02%	68
2015 Q3	$106K	Hold	1,950	–	–	0.03%	64
2015 Q2	$131K	Sell	1,950 -250	-11%	-$16.3K	0.04%	54
2015 Q1	$129K	Buy	+2,200	New	+$133K	0.04%	53
2014 Q4	–	Sell	-2,200	Closed	-$127K	–	28
2014 Q3	$127K	Hold	2,200	–	–	0.04%	54
2014 Q2	$124K	Hold	2,200	–	–	0.04%	65
2014 Q1	$113K	Sell	2,200 -3,000	-58%	-$152K	0.04%	63
2013 Q4	$275K	Buy	5,200 +3,000	+136%	+$147K	0.13%	43
2013 Q3	$98K	Hold	2,200	–	–	0.06%	52
2013 Q2	$91K	Buy	+2,200	New	+$96.2K	0.06%	47

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Veritas Investment Management's ABBV Position: Q4 2020 in Review

Veritas Investment Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 1,400 shares — an estimated $123K sold.

Veritas Investment Management first reported a position in ABBV in Q2 2013 and held it in 29 quarters. The position peaked at $275K in Q4 2013. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

Veritas Investment Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
Veritas Investment Management sold 1,400 AbbVie shares in Q4 2020, an estimated $123K.
Veritas Investment Management first reported a position in AbbVie in Q2 2013 and held it in 29 quarters.
Veritas Investment Management's AbbVie position peaked at $275K in Q4 2013.
2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Veritas Investment Management's 13F filing for Q4 2020.